Survival analysis demonstrated that COAD patients with CDC42 expression in the lower quartile had reduced survival probability compared to those with higher CDC42 expression, while ESR2 expression did not show a significant survival difference (Figure 14F,G). Here, CDC42 is linked to colon adenocarcinoma.